AnalystsKambiz YazdiKambiz Yazdi's Stock Forecasts
AnalystsKambiz Yazdi
Sectors:
Industries:
Analyst Ranking
Top 28%
#1401 out of 5116 analysts
Average Return
+39.2%
Win Rate
73%8 out of 11
Risk vs Reward
Poor
Good
Kambiz Yazdi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +213.27% | $15.15 | $47.46 | 2023-06-02 - 2024-05-31 | Strong Buy |
Avalo Therapeutics IncAVTX | +122.48% | $8.54 | $19.00 | 2025-03-25 - 2025-11-28 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +97.87% | $15.49 | $30.65 | 2025-03-11 - 2025-11-28 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +46.40% | $10.69 | $15.65 | 2024-08-28 - 2025-08-27 | Strong Buy |
Eyepoint Pharmaceuticals IncEYPT | +34.24% | $8.82 | $11.84 | 2024-08-28 - 2025-08-27 | Strong Buy |
Kambiz Yazdi Analyst Color
Get additional color on Kambiz Yazdi's coverage of popular stocks
Kambiz Yazdi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vtv Therapeutics IncVTVT | 1 | Strong Buy | $40.00 | +49.81% | Initiates Coverage On | 11 days ago |
Praxis Precision Medicines IncPRAX | 3 | Strong Buy | $424.00 | +115.82% | Initiates Coverage On | 11 days ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $50.00 | +14.76% | Initiates Coverage On | 11 days ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $47.00 | +58.20% | Initiates Coverage On | 11 days ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $23.00 | +21.05% | Initiates Coverage On | 8 months ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $19.00 | -38.01% | Maintains | 9 months ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.